ARALEZ PHARMACEUTICALS INC. Operating Cash Flow
ARALEZ PHARMACEUTICALS INC. reported Operating Cash Flow of $18.58 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities for the quarter ending 2018-03-31 was $18.58M, a 77.13% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities for the quarter ending 2017-12-31 was -$9.61M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities for the quarter ending 2017-09-30 was -$15.08M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities for the quarter ending 2017-06-30 was -$14.60M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities for fiscal 2016 was -$83.73M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities for fiscal 2015 was -$16.79M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | $18.58M 10-Q · filed 2018-05-08 | $8.97M derived: sum of 2 quarters · filed 2018-05-08 | -$6.11M derived: sum of 3 quarters · filed 2018-05-08 | -$20.71M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-12-31 | -$9.61M derived: 10-Q 12 month − 10-Q 9 month · filed 2018-05-08 | -$24.69M derived: sum of 2 quarters · filed 2018-05-08 | -$39.29M derived: sum of 3 quarters · filed 2018-05-08 | -$28.80M 10-Q · filed 2018-05-08 | -$28.79M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$15.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$29.68M derived: sum of 2 quarters · filed 2017-11-09 | -$19.19M 10-Q · filed 2017-11-09 | -$34.26M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-06-30 | -$14.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$4.11M 10-Q · filed 2017-08-09 | -$19.18M derived: sum of 3 quarters · filed 2018-05-08 | -$30.12M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-03-31 | $10.49M 10-Q · filed 2018-05-08 | -$4.58M derived: sum of 2 quarters · filed 2018-05-08 | -$15.52M derived: sum of 3 quarters · filed 2018-05-08 | ||
| 2016-12-31 | -$15.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$26.01M derived: sum of 2 quarters · filed 2018-03-14 | -$83.73M 10-K · filed 2018-03-14 | ||
| 2016-09-30 | -$10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$68.66M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$57.72M 10-Q · filed 2017-08-09 | ||||
| 2015-12-31 | -$16.79M 10-K · filed 2018-03-14 |